Episodes

Thursday Apr 15, 2021
Thursday Apr 15, 2021
Plant-based foods are proving they are re not just a passing vegan fancy. Whether its bean-based burgers or veggie pizzas, the plant-based food trend in the North America has grown from virtual obscurity to become an important segment of the North American diet. Several drivers have spurred phenomenal growth in the sector including healthier eating habits, increased concern for climate and limited natural resources, as well as new techniques that have turned boring veggies into tasty feasts. More and more, consumers are opting for simple, wholesome ingredients in products that taste good. This trend only accelerated as the pandemic took hold, evidenced by Nielsen’s report that alternative meat sales increased 454% in the third week of March 2020 compared to the same week in 2019. Nielsen’s data shows that plant-based meat and milk sales skyrocketed, far outpacing conventional meat and milk sales as Americans stocked up on food during the pandemic. This giant wave of plant-based food demand doesn’t appear temporary but likely represents a lasting shift in consumer preferences. Not counting the pandemic surge in growth, the plant-based food sector ballooned over 33-fold during the last 15 years, with no signs of slowing. As a result, plant-based online groceries are also thriving as sustainability-focused products are growing more than five times faster than other product categories, generating the highest growth in the consumer goods sector. Operating at the intersection of three high-growth sectors — plant-based products, e-commerce/technology and consumer-packaged goods — PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) (Profile) is fast becoming the premier digital interface for plant-oriented consumers. As the first public company known to be fully focused on the plant-based e-commerce space, PlantX intends to leverage its first-mover status to become the global go-to place for everything plant-based. As it works to become, first and foremost, an e-commerce platform that carries multiple plant-based brands under one roof, PlantX looks to be following the model implemented by Amazon.com Inc. (NASDAQ: AMZN), which has become renowned for carrying a huge variety of products under one roof. PlantX is also following steps taken by both Amazon and Apple to succeed through both educating and serving its customers. Others in the plant-based sector, including Beyond Meat Inc. (NASDAQ: BYND) and The Very Good Food Company Inc. (OTCQB: VRYYF), have a narrower focus on the development and sale of alternative meats, while US Vegan Climate ETF (NYSE ARCA: VEGN) has made a significant commitment to sustainability by not investing in any company that hurts the environment or harms animals.
![Lottery.com Strategically Positioned as Digital Lottery Operations Gain Global Traction [Video Edition]](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog8013814/Lottery_300x300.jpg)
Monday Apr 12, 2021
Monday Apr 12, 2021
With a worldwide pandemic raging, industries that were already moving toward digital applications have accelerated the process. People now grab their mobile device for everything from ordering groceries to buying cars — and the trend isn’t likely to end any time soon. The founders of Lottery.com (Profile) recognized the shifting trends years ago and were first movers to address the untapped global lottery market. The company uniquely combines blockchain with other cutting-edge technology to offer at-home lottery participation and aims to capture a lion’s share of huge lottery and sports betting markets. Now the company is timing its entry into the public markets with another hot trend: investor appetite for special purpose acquisition companies, or SPACs. The entire gambling and gaming industry is likely to explode as the pandemic subsides and the economy gets its legs back. DraftKings Inc. (NASDAQ: DKNG) used the SPAC path to go public last April, and traditional casinos are expecting revenue resurgence post-pandemic, with companies such as Bally’s Corporation (NYSE: BALY), MGM Resorts International (NYSE: MGM) and Penn National Gaming Inc. (NASDAQ: PENN) all eager for a return to normalcy.

Monday Apr 12, 2021
Monday Apr 12, 2021
With a worldwide pandemic raging, industries that were already moving toward digital applications have accelerated the process. People now grab their mobile device for everything from ordering groceries to buying cars — and the trend isn’t likely to end any time soon. The founders of Lottery.com (Profile) recognized the shifting trends years ago and were first movers to address the untapped global lottery market. The company uniquely combines blockchain with other cutting-edge technology to offer at-home lottery participation and aims to capture a lion’s share of huge lottery and sports betting markets. Now the company is timing its entry into the public markets with another hot trend: investor appetite for special purpose acquisition companies, or SPACs. The entire gambling and gaming industry is likely to explode as the pandemic subsides and the economy gets its legs back. DraftKings Inc. (NASDAQ: DKNG) used the SPAC path to go public last April, and traditional casinos are expecting revenue resurgence post-pandemic, with companies such as Bally’s Corporation (NYSE: BALY), MGM Resorts International (NYSE: MGM) and Penn National Gaming Inc. (NASDAQ: PENN) all eager for a return to normalcy.
![FACT Inc. (FCTI) Leverages Proprietary Technology to Enter Surging NFT Market [Video Edition]](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog8013814/FCTI_vcqd9i_300x300.jpg)
Friday Apr 09, 2021
Friday Apr 09, 2021
Despite COVID-19’s impact on galleries, auction houses and retailers, the global art market circulated more than $50 billion in art, while other collectibles such as coins and trading cards saw record sales. Amazingly, an estimated 10% of art is stolen annually, and an estimated 50% of all sports memorabilia is estimated to be fake per the FBI. To get a flavor of just how difficult it is to know if something is stolen and replaced with a near-perfect forgery, Interpol’s stolen artwork database has more than 50,000 items across 134 countries listed in it. Experts note that scams and hacks are already hitting the exploding market of digital collectables known as NFT’s (non-fungible tokens). Taking the collectables world by storm, a non-fungible token is a unit of data on a blockchain ledger that represents a unique underlying asset. As with most other things, crooks flock to where the money is, and right now NFT’s provide plenty of money and new vulnerabilities. That’s exactly why FACT Inc. (OTC: FCTI) (Profile), a recognized global leader of fine art and collectible authentication technology, has recently expanded into the burgeoning NFT market. Shares of companies with interest in or association with NFT’s have enjoyed a nice advance lately, including CurrencyWorks Inc. (OTC: CWRK), Takung Art Co. Ltd. (NYSE American: TKAT), Oriental Culture Holding LTD (NASDAQ: OCG) and Jiayin Group Inc. (NASDAQ: JFIN), as investors seek exposure to the popular technology in the collectables market.

Friday Apr 09, 2021
Friday Apr 09, 2021
Despite COVID-19’s impact on galleries, auction houses and retailers, the global art market circulated more than $50 billion in art, while other collectibles such as coins and trading cards saw record sales. Amazingly, an estimated 10% of art is stolen annually, and an estimated 50% of all sports memorabilia is estimated to be fake per the FBI. To get a flavor of just how difficult it is to know if something is stolen and replaced with a near-perfect forgery, Interpol’s stolen artwork database has more than 50,000 items across 134 countries listed in it. Experts note that scams and hacks are already hitting the exploding market of digital collectables known as NFT’s (non-fungible tokens). Taking the collectables world by storm, a non-fungible token is a unit of data on a blockchain ledger that represents a unique underlying asset. As with most other things, crooks flock to where the money is, and right now NFT’s provide plenty of money and new vulnerabilities. That’s exactly why FACT Inc. (OTC: FCTI) (Profile), a recognized global leader of fine art and collectible authentication technology, has recently expanded into the burgeoning NFT market. Shares of companies with interest in or association with NFT’s have enjoyed a nice advance lately, including CurrencyWorks Inc. (OTC: CWRK), Takung Art Co. Ltd. (NYSE American: TKAT), Oriental Culture Holding LTD (NASDAQ: OCG) and Jiayin Group Inc. (NASDAQ: JFIN), as investors seek exposure to the popular technology in the collectables market.
![ISW Holdings Inc. (ISWH) Unique Approach Secures Foothold in Global Cryptocurrency Market [Video Edition]](https://pbcdn1.podbean.com/imglogo/image-logo/8013814/MNW_300x300.jpg)
Thursday Apr 01, 2021
Thursday Apr 01, 2021
Identifying and staying in front of market trends and emerging sectors has always been a challenge for everyone from “big money” to the retail investor. Two of the most bullish market segments in the last couple years have been cryptocurrency and telehealth, both with tailwinds that were fanned by the pandemic to accelerate consumer adoption and magnified market awareness. Institutional money has been pouring into each, further adding to the momentum and validating investment theses. It’s difficult to get exposure to both from a single company, but diversification is the mantra of ISW Holdings Inc. (OTC: ISWH) (Profile), which has been actively growing its portfolio in both cryptocurrency and healthcare, which complements its logistics and supply chain management division. There are only a select few public companies that offer such diverse opportunity under one umbrella. CleanSpark Inc. (NASDAQ: CLSK) operates in software and technology in addition to its Bitcoin mining fleet. Others have diversified outside crypto such as Marathon Digital Holdings Inc. (NASDAQ: MARA), HIVE Blockchain Technologies Ltd (OTCQX: HVBTF) and Canaan Inc. (NASDAQ: CAN).

Thursday Apr 01, 2021
Thursday Apr 01, 2021
Identifying and staying in front of market trends and emerging sectors has always been a challenge for everyone from “big money” to the retail investor. Two of the most bullish market segments in the last couple years have been cryptocurrency and telehealth, both with tailwinds that were fanned by the pandemic to accelerate consumer adoption and magnified market awareness. Institutional money has been pouring into each, further adding to the momentum and validating investment theses. It’s difficult to get exposure to both from a single company, but diversification is the mantra of ISW Holdings Inc. (OTC: ISWH) (Profile), which has been actively growing its portfolio in both cryptocurrency and healthcare, which complements its logistics and supply chain management division. There are only a select few public companies that offer such diverse opportunity under one umbrella. CleanSpark Inc. (NASDAQ: CLSK) operates in software and technology in addition to its Bitcoin mining fleet. Others have diversified outside crypto such as Marathon Digital Holdings Inc. (NASDAQ: MARA), HIVE Blockchain Technologies Ltd (OTCQX: HVBTF) and Canaan Inc. (NASDAQ: CAN).
![Clean Power Capital Corp. (CSE: MOVE) (FWB: 2K6) (OTC: MOTNF) Subsidiary Establishing Hydrogen Fueling Station Network to Meet Imminent Demand [Video Edition]](https://pbcdn1.podbean.com/imglogo/image-logo/8013814/MNW_300x300.jpg)
Thursday Apr 01, 2021
Thursday Apr 01, 2021
Cars and trucks powered by hydrogen, the most abundant resource in the universe, are on the road now with more planned and in production. Hydrogen power may well be the solution to truly weaning from fossil fuels, turning the tide on CO2 emissions and ushering in a new era of emission-free transportation — but only if vehicles running on the power can find fuel. Even with major automakers rolling out new hydrogen vehicles and a wealth of hydrogen in the universe, there’s a serious shortage of hydrogen fueling stations. With less than 100 public hydrogen stations in the USA, hydrogen fueling stations are the missing infrastructure critical to propel and sustain hydrogen vehicle growth. Using patented next-generation technology, Clean Power Capital Corp. (CSE: MOVE) (FWB: 2K6) (OTC: MOTNF) (Profile) intends to rectify the paucity of hydrogen fueling stations and become a powerful factor as ever more hydrogen vehicles take to the road. Clean Power Capital owns 94.5% of PowerTap Hydrogen Fueling Corp., which builds, installs and supports low-cost, onsite hydrogen fueling and dispensing units. PowerTap’s 2nd Generation technology has 14 installations already in place in the USA (which are not owned by PowerTap Hydrogen Fueling Corp.). The company inked a deal in January with the Andretti Group to install PowerTap’s 3rd Generation modular hydrogen fueling stations starting in California this year. This is just one of many partnerships planned with major fueling networks to install hydrogen fuel technology at existing locations across the nation, and the rollout can’t come too soon. Toyota Motor Corporation (NYSE: TM) recently revealed it has developed and plans on selling a product this year that packages a fuel cell system into a compact module. Integrating the main components of a fuel cell makes it easily adaptable for rapid development and manufacture of a variety fuel cell products. Credited for creating the first commercially market for hydrogen fuel cell technology, Plug Power Inc. (NASDAQ: PLUG) is building the hydrogen economy as a leading provider of comprehensive hydrogen fuel-cell turnkey solutions. ITM Power Plc (OTC: ITMPF) manufactures integrated hydrogen energy solutions for grid balancing, energy storage and the production of renewable hydrogen for transport, renewable heat, and chemicals. And Nel ASA (OTC: NLLSF) is a global hydrogen company dedicated to delivering optimal solutions to produce, store and distribute hydrogen from renewable energy.

Thursday Apr 01, 2021
Thursday Apr 01, 2021
Cars and trucks powered by hydrogen, the most abundant resource in the universe, are on the road now with more planned and in production. Hydrogen power may well be the solution to truly weaning from fossil fuels, turning the tide on CO2 emissions and ushering in a new era of emission-free transportation — but only if vehicles running on the power can find fuel. Even with major automakers rolling out new hydrogen vehicles and a wealth of hydrogen in the universe, there’s a serious shortage of hydrogen fueling stations. With less than 100 public hydrogen stations in the USA, hydrogen fueling stations are the missing infrastructure critical to propel and sustain hydrogen vehicle growth. Using patented next-generation technology, Clean Power Capital Corp. (CSE: MOVE) (FWB: 2K6) (OTC: MOTNF) (Profile) intends to rectify the paucity of hydrogen fueling stations and become a powerful factor as ever more hydrogen vehicles take to the road. Clean Power Capital owns 94.5% of PowerTap Hydrogen Fueling Corp., which builds, installs and supports low-cost, onsite hydrogen fueling and dispensing units. PowerTap’s 2nd Generation technology has 14 installations already in place in the USA (which are not owned by PowerTap Hydrogen Fueling Corp.). The company inked a deal in January with the Andretti Group to install PowerTap’s 3rd Generation modular hydrogen fueling stations starting in California this year. This is just one of many partnerships planned with major fueling networks to install hydrogen fuel technology at existing locations across the nation, and the rollout can’t come too soon. Toyota Motor Corporation (NYSE: TM) recently revealed it has developed and plans on selling a product this year that packages a fuel cell system into a compact module. Integrating the main components of a fuel cell makes it easily adaptable for rapid development and manufacture of a variety fuel cell products. Credited for creating the first commercially market for hydrogen fuel cell technology, Plug Power Inc. (NASDAQ: PLUG) is building the hydrogen economy as a leading provider of comprehensive hydrogen fuel-cell turnkey solutions. ITM Power Plc (OTC: ITMPF) manufactures integrated hydrogen energy solutions for grid balancing, energy storage and the production of renewable hydrogen for transport, renewable heat, and chemicals. And Nel ASA (OTC: NLLSF) is a global hydrogen company dedicated to delivering optimal solutions to produce, store and distribute hydrogen from renewable energy.

Monday Mar 29, 2021
Monday Mar 29, 2021
Lottery.com (the “Company”), a leading platform that allows users to play the lottery online, has entered into a binding agreement to acquire Mexican lottery companies JuegaLotto and Aganar to expand its operations to Mexico and throughout Latin America. JuegaLotto is federally licensed to sell international lottery games in Mexico through an authorized federal gaming portal and is licensed for games of chance in other countries throughout Latin America. Aganar is licensed to sell Mexican National Lottery draw games, instant win tickets, and other games of chance online with access to a federally approved online casino and sportsbook gaming license. The closing of the acquisitions is subject to standard closing conditions.
To view the full press release, visit https://nnw.fm/pSKo4
![XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Announces European Approval for 25 Minute COVID-19 PCR Test [Video Edition]](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog8013814/XPHYF_300x300.jpg)
Monday Mar 29, 2021
Monday Mar 29, 2021
XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) and its exclusive German diagnostics development partner, 3a-diagnostics GmbH (“3a”), are pleased to announce the European approval of its point-of-care SARS-CoV-2 (COVID-19) RT-PCR test system (“Covid-ID Lab”). Covid-ID Lab is now registered within the European Union as a commercial in vitro diagnostic (CE-IVD) test.
To view the full press release, visit https://nnw.fm/EO8zl

Monday Mar 29, 2021
Monday Mar 29, 2021
XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) and its exclusive German diagnostics development partner, 3a-diagnostics GmbH (“3a”), are pleased to announce the European approval of its point-of-care SARS-CoV-2 (COVID-19) RT-PCR test system (“Covid-ID Lab”). Covid-ID Lab is now registered within the European Union as a commercial in vitro diagnostic (CE-IVD) test.
To view the full press release, visit https://nnw.fm/EO8zl
![Lottery.com Enters into Binding Agreement to Acquire Mexican Lottery Companies JuegaLotto and Aganar [Video Edition]](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog8013814/Lottery_300x300.jpg)
Sunday Mar 28, 2021
Sunday Mar 28, 2021
Lottery.com (the “Company”), a leading platform that allows users to play the lottery online, has entered into a binding agreement to acquire Mexican lottery companies JuegaLotto and Aganar to expand its operations to Mexico and throughout Latin America. JuegaLotto is federally licensed to sell international lottery games in Mexico through an authorized federal gaming portal and is licensed for games of chance in other countries throughout Latin America. Aganar is licensed to sell Mexican National Lottery draw games, instant win tickets, and other games of chance online with access to a federally approved online casino and sportsbook gaming license. The closing of the acquisitions is subject to standard closing conditions.
![180 Life Sciences Corp. (NASDAQ: ATNF) Developing Groundbreaking Anti-Inflammatory Therapeutics [Video Edition]](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog8013814/ATNF_300x300.jpg)
Friday Mar 26, 2021
Friday Mar 26, 2021
In a natural response to injury or infection, the body produces chemicals that trigger the immune system to release antibodies and proteins plus increase blood flow to the afflicted area, which aids healing and produces inflammation. However, the immune system and the inflammatory processes have pernicious aspects far removed from beneficial healing. In fact, inflammation has been directly linked to a wide variety of physical and mental health maladies. Inflammation is also a symptom of infectious diseases, implicated in noninfectious diseases, and new findings show a causal relationship with postsurgical trauma. Inflammatory diseases are recognized as the most significant cause of death in the world, with more than 50% of all deaths attributed to inflammation-related diseases. The recognition of the connection between inflammation and disease sparked a flurry of biotech research and a new generation of drug development to treat previously untreatable disorders. World renowned scientists that now lead 180 Life Sciences Corp. (NASDAQ: ATNF) (180 Profile) pioneered the research and development of one of the first anti-inflammatory therapeutics to ever reach market, and today these drugs generate multiple billions of dollars in annual sales. Critical to creation of some the most important and profitable drugs ever on the market, the 180 team is in hot pursuit of new anti-inflammatory blockbusters with active programs in both preclinical and clinical studies. The world’s largest and most broadly based health-care company, Johnson & Johnson (NYSE: JNJ), owns Remicade (infliximab), a blockbuster several times over with approved use in a range of inflammatory diseases. The founders of 180 Life Sciences discovered the anti-TNF (tumor necrosis factor) drug class that led to the development of Remicade and to a $4.9 billion merger between JNJ and Centocor Biotech. AbbVie Inc. (NYSE: ABBV) owns Humira, an anti-TNF therapeutic and top-selling drug in the world. The scientists at 180 Life Sciences licensed the anti-TNF technology in development of Humira. One of the world’s leading biotech’s, Amgen Inc. (NASDAQ: AMGN), bought Celgene’s blockbuster anti-inflammatory drug Otezla in 2019 for $13.4 billion in cash, and Eli Lilly (NYSE: LLY) recently announced a deal for Rigel Pharmaceuticals’ autoimmune and inflammatory diseases treatment for $960 million. In addition to delivering much-needed relief for previously untreatable maladies, eye-popping sales and king-sized acquisitions are likely to accelerate in the anti-inflammatory space, as more new and highly effective drugs come to market.
![Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Poised to Profit as Investor Interest in Psychedelic Therapeutics Market Increases [Video Edition]](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog8013814/CYBN_032921_300x300.jpg)
Friday Mar 26, 2021
Friday Mar 26, 2021
The push for psychedelic medicine is surging across North America and around the world. Scientific evidence supports the life-changing impact this safe and natural alternative has in treating mental illness of all types. New research from a number of organizations, including Johns Hopkins in Baltimore and Imperial College in London, which revealed that patients with depressive disorders had a clinically significant positive response to psilocybin-assisted therapy may represent a therapeutic breakthrough in treating multiple neurological disorders. As research expands, so does support for the revolutionary treatment, which has actually been around for centuries. As seen before, anecdotal opinions often trigger scientific research which then, with validation, drives growth in the industry as well investor interest. That’s exactly what’s occurring in the psychedelic therapeutics space, major upticks in both new companies entering the space as well as investors excited about the possibilities. Potential stakeholders in this game-changing new market are looking for companies that can weather the complex and expensive process of running clinical trials and bringing a drug to market. A leader in psychedelic therapeutic research and drug development, Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) (Profile) has a strong clinical pipeline with phase 2 trials underway, holds ten provisional patents, and boasts a proven leadership and a time-tested tradition. Other companies vying for position in the psychedelics medicine space include COMPASS Pathways Plc (NASDAQ: CMPS), Mind Medicine Inc (OTCQB: MMEDF) (NEO: MMED), Numinus Wellness Inc. (OTC: LKYSF) (NEO: NUMI) (TSX.V: NUMI) and Field Trip Health Ltd. (OTCQX: FTRPF) (CSE: FTRP). Each of these companies is focused on providing better treatments for the millions suffering from mental health issues.

Friday Mar 26, 2021
Friday Mar 26, 2021
In a natural response to injury or infection, the body produces chemicals that trigger the immune system to release antibodies and proteins plus increase blood flow to the afflicted area, which aids healing and produces inflammation. However, the immune system and the inflammatory processes have pernicious aspects far removed from beneficial healing. In fact, inflammation has been directly linked to a wide variety of physical and mental health maladies. Inflammation is also a symptom of infectious diseases, implicated in noninfectious diseases, and new findings show a causal relationship with postsurgical trauma. Inflammatory diseases are recognized as the most significant cause of death in the world, with more than 50% of all deaths attributed to inflammation-related diseases. The recognition of the connection between inflammation and disease sparked a flurry of biotech research and a new generation of drug development to treat previously untreatable disorders. World renowned scientists that now lead 180 Life Sciences Corp. (NASDAQ: ATNF) (180 Profile) pioneered the research and development of one of the first anti-inflammatory therapeutics to ever reach market, and today these drugs generate multiple billions of dollars in annual sales. Critical to creation of some the most important and profitable drugs ever on the market, the 180 team is in hot pursuit of new anti-inflammatory blockbusters with active programs in both preclinical and clinical studies. The world’s largest and most broadly based health-care company, Johnson & Johnson (NYSE: JNJ), owns Remicade (infliximab), a blockbuster several times over with approved use in a range of inflammatory diseases. The founders of 180 Life Sciences discovered the anti-TNF (tumor necrosis factor) drug class that led to the development of Remicade and to a $4.9 billion merger between JNJ and Centocor Biotech. AbbVie Inc. (NYSE: ABBV) owns Humira, an anti-TNF therapeutic and top-selling drug in the world. The scientists at 180 Life Sciences licensed the anti-TNF technology in development of Humira. One of the world’s leading biotech’s, Amgen Inc. (NASDAQ: AMGN), bought Celgene’s blockbuster anti-inflammatory drug Otezla in 2019 for $13.4 billion in cash, and Eli Lilly (NYSE: LLY) recently announced a deal for Rigel Pharmaceuticals’ autoimmune and inflammatory diseases treatment for $960 million. In addition to delivering much-needed relief for previously untreatable maladies, eye-popping sales and king-sized acquisitions are likely to accelerate in the anti-inflammatory space, as more new and highly effective drugs come to market.

Friday Mar 26, 2021
Friday Mar 26, 2021
The push for psychedelic medicine is surging across North America and around the world. Scientific evidence supports the life-changing impact this safe and natural alternative has in treating mental illness of all types. New research from a number of organizations, including Johns Hopkins in Baltimore and Imperial College in London, which revealed that patients with depressive disorders had a clinically significant positive response to psilocybin-assisted therapy may represent a therapeutic breakthrough in treating multiple neurological disorders. As research expands, so does support for the revolutionary treatment, which has actually been around for centuries. As seen before, anecdotal opinions often trigger scientific research which then, with validation, drives growth in the industry as well investor interest. That’s exactly what’s occurring in the psychedelic therapeutics space, major upticks in both new companies entering the space as well as investors excited about the possibilities. Potential stakeholders in this game-changing new market are looking for companies that can weather the complex and expensive process of running clinical trials and bringing a drug to market. A leader in psychedelic therapeutic research and drug development, Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) (Profile) has a strong clinical pipeline with phase 2 trials underway, holds ten provisional patents, and boasts a proven leadership and a time-tested tradition. Other companies vying for position in the psychedelics medicine space include COMPASS Pathways Plc (NASDAQ: CMPS), Mind Medicine Inc (OTCQB: MMEDF) (NEO: MMED), Numinus Wellness Inc. (OTC: LKYSF) (NEO: NUMI) (TSX.V: NUMI) and Field Trip Health Ltd. (OTCQX: FTRPF) (CSE: FTRP). Each of these companies is focused on providing better treatments for the millions suffering from mental health issues.
![Knightscope, Inc. Provides Critical Tools to Law Enforcement, Security Market [Video Edition]](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog8013814/Knight_300x300.jpg)
Thursday Mar 25, 2021
Thursday Mar 25, 2021
The U.S. is a global military superpower, providing its 2.4 million active and reserve troops with every conceivable capability through a massive military industrial complex. Big budgets and copious defense contractors design and build just about anything a soldier could possibly need. To protect our nation and our troops, that’s exactly the way it should be. However, the same commitment, resources and support aren’t afforded to the nation’s 2+ million law enforcement and security personnel, a dedicated and highly skilled group of professionals often left with little more than the technical equivalent of a #2 pencil and notepad to protect 330+ million Americans. Knightscope, Inc. (Profile) is on a crusade to deliver much-needed technological innovation to the law enforcement and security markets to more efficiently and effectively protect the people and property of America from coast-to-coast. The company’s unique combination of self-driving autonomous technology, robotics and A.I. provides law enforcement and security professionals smart eyes & ears. This technological innovation allows humans make decisions faster, smarter and safer while machines do the monotonous, computationally heavy and often dangerous work. Knightscope’s robotic expertise incorporates the best attributes from varied industries, such as the adeptness of defense contractors Lockheed Martin Corporation (NYSE: LMT) and General Dynamics Corporation (NYSE: GD), as well as the autonomous aptitude of Velodyne Lidar Inc. (NASDAQ: VLDR) and the abilities of vehicle electrification being led by Tesla Inc. (NASDAQ: TSLA).
![Amesite Inc. (NASDAQ: AMST) Streamlines Virtual Schooling with AI-driven Online Learning Platform [Video Edition]](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog8013814/AMST_300x300.jpg)
Thursday Mar 25, 2021
Thursday Mar 25, 2021
Inexorable forces are propelling the growth of e-learning at a blistering pace. Online-learning markets were ignited by high education costs, business training programs and a wave of tech innovations, then scorching pandemic demand turned the market into an inferno. The market has legs far beyond the pandemic with constant requests coming from businesses, universities and K-12 schools, eager to train and upskill workers. Little wonder a myriad of companies look to gain traction in the space since the online education market that stood at just $144 billion in 2019 is expected to catapult past $374 billion by 2026. Even more astounding is that these stellar-growth projections are pre-pandemic numbers, and market estimates should easily blow past current forecasts. However, to deliver e-learning that works, tech platforms must address and meet the widely disparate needs of individual schools and varied businesses. A one-size-fits-all approach is doomed to fail when trying to educate, especially in a virtual venue. There’s a critical need for tailored programs as well as wholesale improvement in the way content is created and delivered. Technology innovator Amesite Inc. (NASDAQ: AMST) (Profile) has established a new paradigm in e-learning. The company has created what is arguably the most advanced artificial intelligence driven online learning platform in the entire industry. With the capacity to upload an organization’s entire training and educational materials into a single point of access, Amesite’s customizable SaaS (software-as-a-service) platform is engaging, easy to use and delivers concrete measurable results. The company’s cloud-based platform and content creation services uniquely provide fully managed learning environments that easily integrate and work for business, universities, and K-12 schools. Taking a different tack, Chegg Inc. (NYSE: CHGG) operates direct-to-student learning platforms as well as provides digital textbook rentals, online tutoring and other student services. SaaS behemoth Microsoft Corporation (NASDAQ: MSFT) offers a portfolio of business training applications and Office 365 Education for students, faculty and staff to meet virtually, create content and share resources. This transformation of the education experience is made possible by technology from companies such as Cloudflare Inc. Class A (NYSE: NET), which protects and accelerates internet applications online without adding hardware or installing software, and Zoom Video Communications Inc. (NASDAQ: ZM), which easily connects people through frictionless video, voice, chat and content sharing across multiple devices and diverse locations.

Thursday Mar 25, 2021
Knightscope, Inc. Provides Critical Tools to Law Enforcement, Security Market
Thursday Mar 25, 2021
Thursday Mar 25, 2021
The U.S. is a global military superpower, providing its 2.4 million active and reserve troops with every conceivable capability through a massive military industrial complex. Big budgets and copious defense contractors design and build just about anything a soldier could possibly need. To protect our nation and our troops, that’s exactly the way it should be. However, the same commitment, resources and support aren’t afforded to the nation’s 2+ million law enforcement and security personnel, a dedicated and highly skilled group of professionals often left with little more than the technical equivalent of a #2 pencil and notepad to protect 330+ million Americans. Knightscope, Inc. (Profile) is on a crusade to deliver much-needed technological innovation to the law enforcement and security markets to more efficiently and effectively protect the people and property of America from coast-to-coast. The company’s unique combination of self-driving autonomous technology, robotics and A.I. provides law enforcement and security professionals smart eyes & ears. This technological innovation allows humans make decisions faster, smarter and safer while machines do the monotonous, computationally heavy and often dangerous work. Knightscope’s robotic expertise incorporates the best attributes from varied industries, such as the adeptness of defense contractors Lockheed Martin Corporation (NYSE: LMT) and General Dynamics Corporation (NYSE: GD), as well as the autonomous aptitude of Velodyne Lidar Inc. (NASDAQ: VLDR) and the abilities of vehicle electrification being led by Tesla Inc. (NASDAQ: TSLA).

